Teva Appeals Plavix Ruling To Federal Circuit

Law360, New York (August 15, 2007, 12:00 AM EDT) -- Teva Pharamaceuticals USA Inc. has challenged a judge's decision blocking the generic drug maker from horning in on the market for the blockbuster blood-thinning drug Plavix, in a case in which Teva agreed to be bound by the same judge's ruling on a challenge to Sanofi's Plavix patent by Apotex in a separate case.

Teva filed its notice of appeal on Monday, looking to take its case to the U.S. Court of Appeals for the Federal Circuit. In the Apotex case, U.S. District Judge Sidney H....
To view the full article, register now.